🔎 Trials Near Me

Hjem › Neuroblastom › District of Columbia › Washington

Kliniske studier for Neuroblastom i Washington, DC

11 studier for Neuroblastom søker deltakere på steder i og rundt Washington (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

RekruttererFase 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Alder 18 til 120 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06041516

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • National Institutes of Health Clinical Center, Bethesda · 7 mi unna
4 Weeks · Alle kjønn · Oppdatert 2. okt. 2026 · NCT01109394

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

RekruttererFase 3
  • Children's National Medical Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mi unna
Opp til 30 år · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06172296

Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma

RekruttererFase 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Alder 3 til 35 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06995872

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

RekruttererObservasjonsstudie
  • National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Alder 4 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT01005654

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

RekruttererFase 3
  • Children's National Medical Center, Washington D.C.
365 Days – 30 Years · Alle kjønn · Oppdatert 25. aug. 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

RekruttererFase 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04851119

Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

RekruttererFase 1
  • Children's National Hospital, Washington D.C.
  • Childrens National Hospital, Washington D.C.
Alder 1 til 23 · Alle kjønn · Oppdatert 13. aug. 2026 · NCT07172958

SPEARHEAD-3 Pediatric Study

RekruttererFase 1/2
  • National Institutes of Health, Bethesda · 7 mi unna
Alder 2 til 21 · Alle kjønn · Oppdatert 11. aug. 2026 · NCT05642455

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

RekruttererFase 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Alle kjønn · Oppdatert 19. mai 2026 · NCT04901702

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

RekruttererFase 2
  • Children's National Medical Center, Washington D.C.
18 Months – 40 Years · Alle kjønn · Oppdatert 12. aug. 2025 · NCT05135975

Neuroblastom-studier i andre byer

Andre studier i Washington

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.